glp 1 drugs and crohn's disease Relevance of Glucagon-Like Peptide (GLP-1) in Inflammatory Bowel Diseases: A Narrative Review GLP-1 based therapies and disease

FDA approval for its once-daily oral semaglutide (Wegovy) tablet, becoming the first oral GLP-1 receptor agonist approved for chronic weight management in adults with obesity or overweight conditions

The Bigger Concern: Leaving a Deficiency Untreated When weighing the minimal risks of B12 injections, it helps to consider the well-documented risks of an untreated B12 deficiency

Figure 1: Diurnal (daily) cortisol trend, based on a summary of 15 different research studies (Miller 2016)

10.1016/j.autrev.2004.07.036 9 AshwoodP.KrakowiakP.Hertz-PicciottoI.HansenR.PessahI.Van De WaterJ

Eryptosis is induced by several types of stresses, in particular by entry of Ca 2+ ions followed by the loss of potassium ions, cell shrinkage, exposure of exoplasmic phosphatidylserine, and recognition by phagocytes

Temporal nutritional and inflammatory changes in children with severe head injury fed a regular or an immune-enhancing diet: a randomized, controlled trial